Literature DB >> 19048269

Forensic toxicology findings in deaths involving gamma-hydroxybutyrate.

Fredrik C Kugelberg1, Anita Holmgren, Arne Eklund, Alan Wayne Jones.   

Abstract

Concentrations of the illicit drug gamma-hydroxybutyrate (GHB) were determined in femoral venous blood and urine obtained at autopsy in a series of GHB-related deaths (N = 49). The analysis of GHB was done by gas chromatography after conversion to gamma-butyrolactone and quantitation of the latter with a flame ionization detector. The cutoff concentration of GHB in femoral blood or urine for reporting positive results was 30 mg/L. The deceased were mainly young men (86%) aged 26.5 +/- 7.2 years (mean +/- SD), and the women (14%) were about 5 years younger at 21.4 +/- 5.0 years. The mean, median, and highest concentrations of GHB in femoral blood (N = 37) were 294, 190, and 2,200 mg/L, respectively. The mean urine-to-blood ratio of GHB was 8.8, and the median was 5.2 (N = 28). In 12 cases, the concentrations of GHB in blood were negative (<30 mg/L) when the urine contained 350 mg/L on average (range 31-1,100 mg/L). Considerable poly-drug use was evident in these GHB-related deaths: ethanol (18 cases), amphetamine (12 cases), and various prescription medications (benzodizepines, opiates, and antidepressants) in other cases. Interpreting the concentrations of GHB in postmortem blood is complicated because of concomitant use of other psychoactive substances, variable degree of tolerance to centrally acting drugs, and the lack of reliable information about survival time after use of the drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048269     DOI: 10.1007/s00414-008-0299-2

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  44 in total

Review 1.  Gamma-hydroxybutyrate associated deaths.

Authors:  N Timby; A Eriksson; K Boström
Journal:  Am J Med       Date:  2000-04-15       Impact factor: 4.965

Review 2.  Unravelling the brain targets of gamma-hydroxybutyric acid.

Authors:  Vincenzo Crunelli; Zsuzsa Emri; Nathalie Leresche
Journal:  Curr Opin Pharmacol       Date:  2005-12-20       Impact factor: 5.547

3.  Adverse events, including death, associated with the use of 1,4-butanediol.

Authors:  D L Zvosec; S W Smith; J R McCutcheon; J Spillane; B J Hall; E A Peacock
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

4.  Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.

Authors:  M A Carai; G Colombo; G Brunetti; S Melis; S Serra; G Vacca; S Mastinu; A M Pistuddi; C Solinas; G Cignarella; G Minardi; G L Gessa
Journal:  Eur J Pharmacol       Date:  2001-10-12       Impact factor: 4.432

5.  Blood, brain, and hair GHB concentrations following fatal ingestion.

Authors:  K S Kalasinsky; M M Dixon; G A Schmunk; S J Kish
Journal:  J Forensic Sci       Date:  2001-05       Impact factor: 1.832

6.  Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period.

Authors:  Michael Scott-Ham; Fiona C Burton
Journal:  J Clin Forensic Med       Date:  2005-08

7.  Nonfatal instances of intoxication with gamma-hydroxybutyrate in the United Kingdom.

Authors:  Simon P Elliott
Journal:  Ther Drug Monit       Date:  2004-08       Impact factor: 3.681

8.  High mortality rates among GHB abusers in Western Sweden.

Authors:  Kai Knudsen; Joachim Greter; Mario Verdicchio
Journal:  Clin Toxicol (Phila)       Date:  2008-03       Impact factor: 4.467

9.  Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity.

Authors:  C Jones
Journal:  J Clin Forensic Med       Date:  2001-06

10.  Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia.

Authors:  David G E Caldicott; Fiona Y Chow; Brian J Burns; Peter D Felgate; Roger W Byard
Journal:  Med J Aust       Date:  2004-09-20       Impact factor: 7.738

View more
  11 in total

Review 1.  Postmortem toxicology.

Authors:  Gisela Skopp
Journal:  Forensic Sci Med Pathol       Date:  2010-03-04       Impact factor: 2.007

2.  The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important.

Authors:  J Kietzerow; B Otto; N Wilke; H Rohde; S Iwersen-Bergmann; H Andresen-Streichert
Journal:  Int J Legal Med       Date:  2019-10-09       Impact factor: 2.686

3.  Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway.

Authors:  Muhammad S Al-Samarraie; Ritva Karinen; Jørg Mørland; Mimi Stokke Opdal
Journal:  Eur J Clin Pharmacol       Date:  2010-08-18       Impact factor: 2.953

4.  Monocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept Study.

Authors:  Marilyn E Morris; Bridget L Morse; Gloria J Baciewicz; Matthew M Tessena; Nicole M Acquisto; David J Hutchinson; Robert Dicenzo
Journal:  J Clin Toxicol       Date:  2011-11-10

5.  The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion.

Authors:  Paul I Dargan; Jenny Button; Susie Davies; John Ramsey; Simi George; David W Holt; David M Wood
Journal:  J R Soc Med       Date:  2009-12       Impact factor: 5.344

6.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

7.  Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs.

Authors:  Hilke Andresen-Streichert; P Jensen; J Kietzerow; M Schrot; N Wilke; E Vettorazzi; A Mueller; S Iwersen-Bergmann
Journal:  Int J Legal Med       Date:  2014-08-02       Impact factor: 2.686

8.  Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.

Authors:  Bridget L Morse; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2013-02-07       Impact factor: 4.030

Review 9.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

10.  Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.

Authors:  Evangelia Liakoni; Fabio Walther; Christian H Nickel; Matthias E Liechti
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-08-31       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.